BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 214 filers reported holding BEAM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,168,515 | -34.9% | 136,137 | -16.9% | 0.13% | -35.2% |
| Q4 2022 | $6,405,827 | +21.8% | 163,790 | +48.3% | 0.20% | +14.0% |
| Q3 2022 | $5,261,000 | +67.9% | 110,435 | +36.5% | 0.17% | +60.7% |
| Q2 2022 | $3,133,000 | -49.5% | 80,928 | -25.2% | 0.11% | -30.5% |
| Q1 2022 | $6,201,000 | -6.7% | 108,227 | +29.8% | 0.15% | +12.4% |
| Q4 2021 | $6,646,000 | -15.9% | 83,392 | -8.2% | 0.14% | -8.7% |
| Q3 2021 | $7,904,000 | -40.1% | 90,840 | -11.4% | 0.15% | -39.0% |
| Q2 2021 | $13,196,000 | +70.7% | 102,523 | +6.1% | 0.25% | +50.0% |
| Q1 2021 | $7,731,000 | -17.0% | 96,591 | -15.3% | 0.16% | -21.5% |
| Q4 2020 | $9,312,000 | +296.9% | 114,058 | +19.7% | 0.21% | +161.2% |
| Q3 2020 | $2,346,000 | -13.3% | 95,285 | -1.4% | 0.08% | -18.4% |
| Q2 2020 | $2,705,000 | +52.9% | 96,598 | -1.7% | 0.10% | +3.2% |
| Q1 2020 | $1,769,000 | – | 98,276 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |